Sturge-Weber Syndrome
Introduction to Sturge-Weber Syndrome in Children
Sturge-Weber Syndrome (SWS), also known as encephalotrigeminal angiomatosis, is a rare congenital neurocutaneous disorder characterized by a facial port-wine birthmark and neurological abnormalities.
Key Points:
- Incidence: Approximately 1 in 20,000 to 50,000 live births
- Etiology: Sporadic (non-inherited) disorder caused by a somatic mosaic mutation
- Pathophysiology: Abnormal development of blood vessels in the brain, skin, and eye
Genetics and Pathophysiology
SWS is caused by a somatic activating mutation in the GNAQ gene on chromosome 9q21. This mutation occurs post-zygotically, leading to a mosaic distribution of affected cells. The mutation results in:
- Overactivation of the RAS-ERK pathway
- Abnormal angiogenesis and vascular malformations
- Impaired vascular development in the brain, leading to leptomeningeal angiomas
Clinical Features of Sturge-Weber Syndrome in Children
Cutaneous Manifestations
- Port-wine birthmark (nevus flammeus):
- Present at birth
- Typically unilateral, involving the forehead and upper eyelid
- Follows the distribution of the ophthalmic branch (V1) of the trigeminal nerve
Neurological Manifestations
- Seizures:
- Often the presenting symptom, typically occurring in the first year of life
- Can be focal or generalized, often difficult to control
- Hemiparesis: Contralateral to the port-wine stain
- Developmental delays and intellectual disability
- Migraine-like headaches
- Stroke-like episodes
Ophthalmological Manifestations
- Glaucoma: Occurs in 30-70% of patients
- Choroidal hemangioma
- Buphthalmos (enlarged eye)
- Visual field defects
Other Features
- Endocrine abnormalities: Growth hormone deficiency, central hypothyroidism
- Sleep disorders
- Behavioral problems: ADHD, autism spectrum disorders
Diagnosis of Sturge-Weber Syndrome in Children
Clinical Diagnosis
Diagnosis is primarily based on clinical features and neuroimaging. The classic triad includes:
- Facial port-wine birthmark
- Leptomeningeal angioma
- Ocular abnormalities
Diagnostic Criteria
Roach Scale for SWS classification:
- Type I: Both facial and leptomeningeal angiomas; may have glaucoma
- Type II: Facial angioma alone; may have glaucoma
- Type III: Isolated leptomeningeal angioma; usually no glaucoma
Diagnostic Tools
- Neuroimaging:
- MRI with contrast: Gold standard for detecting leptomeningeal angiomas
- CT scan: May show characteristic "tram-track" calcifications
- Ophthalmological examination:
- Slit-lamp examination
- Fundoscopy
- Intraocular pressure measurement
- EEG: To evaluate seizure activity
- Genetic testing: For GNAQ gene mutation (not routinely performed)
Differential Diagnosis
- Isolated port-wine birthmark
- Klippel-Trenaunay syndrome
- Parkes Weber syndrome
- Other causes of symptomatic epilepsy in infancy
case of Sturge Weber Syndrome and Suprasellar Arachnoid cyst in a 9 month old baby girl with seizures. Findings:-
• Left temporal and occipital lobe pial enhancement.• Enlargement of glomerula of left lateral ventricle choroid plexus.• Thickening of retina left globe.• Arachnoid cyst suprasellar cistern. (source)
This 8 yo girl presented at birth with large left sided facial nevus involving all three branches of the cutaneous trigeminal nerve. The double contour “gyriform” patterns of intracranial calcifications give “tram tracks” appearance on plain films (source).
Management of Sturge-Weber Syndrome in Children
Multidisciplinary Approach
Management requires coordination among various specialists:
- Pediatric neurologist
- Ophthalmologist
- Dermatologist
- Neurosurgeon
- Psychologist or developmental specialist
- Physical and occupational therapists
Neurological Management
- Seizure control:
- Anticonvulsant medications: Often require polytherapy
- Ketogenic diet: May be beneficial in refractory cases
- Surgical options: Focal resection, hemispherectomy in severe cases
- Stroke-like episode management:
- Low-dose aspirin therapy
- Acute management with hydration and possibly steroids
- Headache management: Migraine prophylaxis and abortive treatments
Ophthalmological Management
- Glaucoma treatment:
- Topical medications
- Surgical interventions: Trabeculectomy, drainage implants
- Regular monitoring for choroidal hemangiomas
- Visual rehabilitation for amblyopia
Dermatological Management
- Laser therapy for port-wine birthmark:
- Pulsed dye laser treatment
- May require multiple sessions
- Cosmetic camouflage techniques
Developmental and Psychosocial Support
- Early intervention programs
- Special education services
- Behavioral therapy for ADHD or autism spectrum disorders
- Psychological support for patients and families
Prognosis and Long-term Care for Children with Sturge-Weber Syndrome
Prognostic Factors
- Extent of brain involvement
- Age at seizure onset
- Response to anticonvulsant therapy
- Presence and severity of glaucoma
Long-term Outcomes
- Cognitive function: Ranges from normal to severe intellectual disability
- Seizure control: Variable, some achieve long-term remission
- Motor function: May have persistent hemiparesis
- Vision: Depends on severity of glaucoma and choroidal involvement
Ongoing Care
- Regular neurological follow-up
- Annual ophthalmological examinations
- Periodic neuroimaging
- Endocrine evaluations
- Educational and vocational planning
- Transition planning for adult care
Quality of Life Considerations
- Psychosocial support for patients and families
- Management of chronic pain and headaches
- Addressing potential stigma associated with visible birthmark
- Support for independence and self-care skills
Current Research and Future Directions in Sturge-Weber Syndrome
Pathophysiology Research
- Further understanding of the GNAQ mutation and its effects
- Investigation of other potential genetic modifiers
- Studies on abnormal angiogenesis and vascular development
Therapeutic Research
- Novel antiepileptic treatments:
- Cannabidiol (CBD) for seizure control
- Responsive neurostimulation devices
- Targeted molecular therapies:
- mTOR inhibitors (e.g., sirolimus) for vascular malformations
- Drugs targeting the RAS-ERK pathway
- Neuroprotective strategies to prevent progression of brain involvement
Diagnostic Advancements
- Improved neuroimaging techniques for early detection
- Development of biomarkers for disease progression
- Prenatal genetic testing possibilities
Clinical Trials
- Ongoing trials for novel anticonvulsants
- Studies on the efficacy of low-dose aspirin for stroke prevention
- Evaluation of new laser technologies for port-wine birthmark treatment
Future Perspectives
- Potential for gene therapy or gene editing approaches
- Development of personalized treatment strategies based on genetic profile
- Improved long-term outcomes through early intervention and novel therapies
Sturge-Weber Syndrome
- Question: What is the primary characteristic of Sturge-Weber Syndrome? Answer: A port-wine birthmark on the face, typically involving the forehead and upper eyelid
- Question: Which side of the face is most commonly affected by the port-wine stain in Sturge-Weber Syndrome? Answer: The same side as the brain involvement
- Question: What is the genetic basis of Sturge-Weber Syndrome? Answer: A somatic mosaic mutation in the GNAQ gene
- Question: Which organ systems are primarily affected in Sturge-Weber Syndrome? Answer: The skin, eyes, and central nervous system
- Question: What is the most common ocular manifestation of Sturge-Weber Syndrome? Answer: Glaucoma
- Question: At what age does glaucoma typically develop in patients with Sturge-Weber Syndrome? Answer: Early childhood, often before 2 years of age
- Question: What is the most common neurological symptom in Sturge-Weber Syndrome? Answer: Seizures
- Question: At what age do seizures typically begin in Sturge-Weber Syndrome? Answer: Before one year of age
- Question: What imaging technique is most useful for diagnosing brain involvement in Sturge-Weber Syndrome? Answer: MRI with contrast
- Question: What characteristic brain finding is seen on imaging in Sturge-Weber Syndrome? Answer: Leptomeningeal angioma
- Question: What is the preferred treatment for seizures in Sturge-Weber Syndrome? Answer: Anticonvulsant medications
- Question: In severe cases of Sturge-Weber Syndrome, what surgical procedure might be considered for seizure control? Answer: Hemispherectomy
- Question: What is the risk of intellectual disability in patients with Sturge-Weber Syndrome? Answer: Approximately 50-60% of patients may have some degree of intellectual disability
- Question: What is the estimated incidence of Sturge-Weber Syndrome? Answer: 1 in 20,000 to 50,000 live births
- Question: Is Sturge-Weber Syndrome typically inherited? Answer: No, it usually occurs sporadically
- Question: What is the preferred treatment for the port-wine stain in Sturge-Weber Syndrome? Answer: Laser therapy
- Question: What type of headaches are common in patients with Sturge-Weber Syndrome? Answer: Migraine-like headaches
- Question: What is the primary cause of visual field defects in Sturge-Weber Syndrome? Answer: Glaucoma
- Question: What is the recommended frequency of ophthalmological examinations for children with Sturge-Weber Syndrome? Answer: Every 3-6 months in early childhood, then annually
- Question: What is the purpose of low-dose aspirin therapy in some patients with Sturge-Weber Syndrome? Answer: To potentially reduce the frequency and severity of stroke-like episodes
- Question: What is the Roach Scale used for in Sturge-Weber Syndrome? Answer: To classify the extent of involvement (skin, brain, and/or eyes)
- Question: What is the typical appearance of calcifications in the brain of Sturge-Weber Syndrome patients? Answer: Tram-track or railroad track appearance on CT scans
- Question: What is the name of the eye condition where increased pressure within the eye can lead to optic nerve damage in Sturge-Weber Syndrome? Answer: Glaucoma
- Question: What is the term for the abnormal blood vessels on the surface of the brain in Sturge-Weber Syndrome? Answer: Leptomeningeal angioma
- Question: What is the risk of developing glaucoma in patients with Sturge-Weber Syndrome who have a port-wine stain involving the eyelids? Answer: Approximately 50%
- Question: What is the primary goal of treatment for Sturge-Weber Syndrome? Answer: Symptom management and prevention of complications
- Question: What type of specialist typically coordinates care for patients with Sturge-Weber Syndrome? Answer: Neurologist
- Question: What is the prognosis for life expectancy in individuals with Sturge-Weber Syndrome? Answer: Generally normal, but quality of life may be impacted by complications
- Question: What is the recommended first-line treatment for port-wine stains in Sturge-Weber Syndrome? Answer: Pulsed dye laser therapy
- Question: What is the primary cause of stroke-like episodes in Sturge-Weber Syndrome? Answer: Impaired blood flow in the affected brain regions
Video Notes
The videos on Pediatime are created using the same notes provided on this platform, with added background soothing music. Each video is concise, lasting around 3-5 minutes, designed to help students and professionals read and review the content quickly and repeatedly. These videos aim to simplify the process of learning and remembering key points of the subject. While they may not cover topics in full depth, they are intended to provide valuable insights and aid in gaining some essential knowledge.
Please pause the video wherever needed, as it may move quickly or provide less time to read. For a comprehensive understanding, always refer to standard textbooks and guidelines.
Disclaimer
The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.
